Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024
Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...
academy6d
New Name and Logo Unveiled for Alkali-resistant Glass Fiber Product Range by Nippon Electric Glass
Nippon Electric Glass Co., Ltd., "NEG," headquartered in Otsu, Japan, announced a new name and logo for its alkali-resistant glass fiber (ARG Fiber) product range. This represents a new stage in the ...